Estimations des analystes de Wall Street pour AngioDynamics, Inc. (ANGO): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 5 |
| Conserver | 6 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 11 |
| Note moyenne (1-5) | 0.46 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-10-01 | $-0.11 | ||
| 2026-07-14 | $-0.07 | $-0.11 | +36.4% |
| 2026-04-02 | $-0.07 | $-0.11 | +36.4% |
| 2026-01-06 | $-0.15 | $-0.10 | -50.0% |
| 2025-10-02 | $-0.10 | $-0.14 | +28.6% |
| 2025-07-15 | $-0.03 | $-0.13 | +76.9% |
| 2025-04-02 | $0.03 | $-0.13 | +123.1% |
| 2025-01-08 | $-0.04 | $-0.11 | +63.6% |
Ratios de valorisation
| Prix / Valeur comptable | 3.75 |
| EV / EBITDA | -16.04 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $349.6M | $344.3M | $359.5M | $264.2M | $291.0M | $316.2M | $338.8M | $303.9M | $292.5M | $320.2M |
| Coût des Ventes | $125.8M | $117.8M | $114.6M | $113.9M | $134.2M | $150.5M | $164.5M | $149.2M | $134.8M | $145.3M |
| Marge Brute | $143.9M | $143.9M | $156.0M | $150.3M | $156.8M | $165.7M | $174.2M | $154.7M | $157.7M | $174.9M |
| R&D | $25.3M | $25.5M | $29.4M | $29.7M | $36.4M | $30.7M | $29.9M | $31.5M | $26.2M | $29.4M |
| Frais Généraux | $110.2M | $108.5M | $116.1M | $116.5M | $117.2M | $133.8M | $144.3M | $144.0M | $145.2M | $157.1M |
| Charges Opérationnelles | $155.1M | $158.0M | $165.4M | $317.4M | $192.1M | $194.2M | $225.4M | $347.1M | $197.7M | $214.8M |
| Résultat Opérationnel | -$11.2M | -$14.2M | -$9.4M | -$167.1M | -$35.3M | -$28.5M | -$51.2M | -$192.4M | -$40.0M | -$39.9M |
| EBITDA | $13.4M | $9.0M | $16.3M | -$143.4M | -$9.3M | $11.1M | $12.2M | -$6.1M | $1.7M | $188000 |
| Charges d'Intérêt | $2.8M | $3.1M | $5.1M | $907000 | $861000 | $688000 | $2.7M | 0 | 0 | $299000 |
| Résultat Avant Impôts | -$14.3M | -$17.3M | -$14.7M | -$168.1M | -$36.1M | -$29.9M | -$54.4M | -$191.6M | -$34.0M | -$36.3M |
| Impôts | -$7.2M | -$11.0M | -$3.6M | -$1.3M | -$4.5M | -$3.4M | -$2.0M | -$7.3M | -$39000 | $442000 |
| Résultat Net | -$7.1M | $16.3M | $61.3M | -$166.8M | -$31.5M | -$26.5M | -$52.4M | -$184.3M | -$34.0M | -$36.7M |
| BPA | $-0.19 | $0.44 | $1.64 | $-4.37 | $-0.82 | $-0.68 | $-1.33 | $-4.59 | $-0.83 | $-0.88 |
| BPA Dilué | $-0.19 | $0.44 | $1.64 | $-4.37 | $-0.82 | $-0.68 | $-1.33 | $-4.59 | $-0.83 | $-0.88 |
| Actions en Circulation (Diluées) | $37.0M | $37.5M | $37.5M | $38.0M | $38.3M | $39.0M | $39.5M | $40.2M | $41.0M | $41.5M |
Prix
| Prix | $15.46 |
| Capitalisation | $639M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: CGEM · FULC · LAB · NMRA · OCGN · OMER · RAPT
Explorer le secteur: Healthcare · Medical - Instruments & Supplies
Plus de sections de ANGO: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions